Barriers and facilitators of pneumococcal vaccination among the elderly

Zimmerman, Richard K.; Santibanez, Tammy A.; Fine, Michael J.; Janosky, Janine E.; Nowalk, Mary Patricia; Bardella, Inis Jane; Raymund, Mahlon; Wilson, Stephen

doi:10.1016/s0264-410x(02)00698-9

Cited by 69 publications

(71 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The under-use of the 23-PPV vaccine might also be caused by physicians themselves being reluctant or unconvinced regarding the safety, efficacy and need for pneumococcal vaccination. 15 Scientific recommendations come first from professional workers. In China, CHC physicians are primarily responsible for the basic health care of elderly people.…”

Section: Discussionmentioning

confidence: 99%

Factors associated with pneumococcal vaccination among an urban elderly population in China

Liu

et al. 2014

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Objectives: To investigate the coverage of the 23-valent pneumococcal polysaccharide vaccine (23-PPV) in the Chinese urban elderly population and to understand the attitudes, knowledge and beliefs of this population toward the 23-PPV vaccination. Methods: A cross-sectional approach was employed to survey the willingness of this population to receive the 23-PPV vaccination. Two thousand 9 hundred 2 six subjects over the age of 60 y were enrolled via a multistage random sampling method from the urban community population in Hangzhou, China. The relationships between the variables and the willingness to receive the 23-PPV vaccination were computed as odds ratios (ORs) by multivariate analysis. Results Of the participants, 21.77% were willing to undergo 23-PPV vaccination, and 61.65% of the subjects agreed that pneumonia is a serious disease among elderly people. The rate of reasonable perceptions about vaccination, including the perception about vaccine efficacy and safety, among the subjects was below 50%. Only 1.23% of subjects had been vaccinated with 23-PPV, and a similarly low rate was observed for the seasonal influenza vaccine (4.17%). The factors that were independently related to the willingness to receive the 23-PPV vaccine included consensus with the hazards of pneumonia (OR D 1.67, 95% CI: 1.28 -2.17), the safety of vaccination (OR D 2.00, 95% CI: 1.54 -2.59), advice about the 23-PPV vaccination from family members (OR D 2.37, 95% CI: 1.39 -4.40), influenza vaccination history (OR D 2.57, 95% CI: 1.66 -3.98) and pneumococcal vaccination history (OR D 7.48, 95% CI: 2.4-22.92). Conclusion: The administration of the 23-PPV vaccine among the urban elderly population is not optimistic in China. Emphasis on persuasion from families and the improvement of knowledge about vaccination might encourage elderly people to get the 23-PPV vaccination. Suggestions from physicians did not affect the participants' willingness to get the 23-PPV vaccination in multivariate analysis, but elderly people typically visited the Community Health Center (CHC) in their residential districts, and thus, systematic encouragement from healthcare physicians might be the key to increasing 23-PPV vaccination.

show abstract

Section: Discussionmentioning

confidence: 99%

Factors associated with pneumococcal vaccination among an urban elderly population in China

Liu

et al. 2014

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

show abstract

“…Previous research into barriers to adult vaccination indicates that physician recommendation is an important factor related to vaccination status, [1][2][3][4][5] and most physicians recognize the value of immunization for disease prevention. 6 Yet for adults Ն65 years, overall vaccination rates of 63% for influenza and 55% for pneumococcal polysaccharide vaccine (PPV) 7 remain substantially below the 90% goal set by Healthy People 2010.…”

mentioning

confidence: 99%

Missed Opportunities to Vaccinate Older Adults in Primary Care

Nowalk

Zimmerman²,

Cleary³

et al. 2005

The Journal of the American Board of Family Medicine

View full text Add to dashboard Cite

Objective: During the 2000 to 2001 influenza season, distribution of influenza vaccine was delayed, and national self-reported vaccination rates declined. The purposes of this study were to characterize missed opportunities for adult vaccinations and assess the impact of the vaccine delay on missed opportunities for influenza vaccination as recorded in medical records.Methods: In a cross-sectional analysis, medical record data from 217 adult patients aged >65 years in primary care practices that received influenza vaccine supplies late in 2000 were used to assess rates and missed opportunities to vaccinate. Missed opportunities were defined as visits in which there was no record that vaccine had been given, discussed, or refused by the patient.Results

show abstract

Section: Barriers To Treatmentmentioning

confidence: 99%

“…[15][16][17] Simply put, if medical practitioners offer and advocate vaccination to their patients, then the great majority of patients will accept it, even when the patient holds negative attitudes towards vaccination. 15 The largest cause of missed opportunities is the failure of physicians to offer vaccination. 16 Doubts amongst physicians as to the efficacy of pneumococcal vaccination do not appear to play a significant part in physicians' failure to offer the pneumococcal vaccine, 17,18 although difficulties in determining the vaccination status of patients and uncertainty as to the safety of revaccination may play a role.…”

Section: Barriers To Treatmentmentioning

confidence: 99%